List of works by Frank V Fossella

1769. The Impact of Checkpoint Inhibitor Immunotherapy on Infections in Lung Cancer Patients

scientific article published on 23 October 2019

A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel and Nintedanib for Resectable Non-Small Cell Lung Cancer

scientific article published on 19 March 2020

A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer

scientific article published in May 2005

A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer

scientific article

Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program

scientific article

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer

scientific article published on 2 January 2018

Biomarkers/Molecular Targets, Immunotherapy, and Treatments for Non-Small Cell Lung Cancer.

scientific article published in July 2016

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis

scientific article

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors

scientific article published on 04 June 2004

Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)"

scientific article published on 01 December 2008

Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials

scientific article

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone

scientific article published on 06 April 2007

Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial

scientific article published on 28 October 2013

Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial

scientific article published on 18 June 2016

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials

scientific article published on 01 February 2001

Docetaxel for previously treated non-small-cell lung cancer

scientific article

Docetaxel for treatment of solid tumours: a systematic review of clinical data

scientific article

Docetaxel in second-line treatment of non-small-cell lung cancer

scientific article

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer

scientific article published on 14 June 2008

Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer

scientific article published in July 2003

Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial

scientific article published on 19 June 2006

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial

scientific article published on April 2004

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).

scientific article

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection

scientific article published on 01 January 2004

High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy

scientific article published on 01 April 2005

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer

scientific article published on 4 December 2017

Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

scientific article published in January 2003

Longitudinal associations between caregiver burden and patient and spouse distress in couples coping with lung cancer

scientific article published on 2 April 2013

Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer

scientific article published in January 2008

Lung cancer patients and their spouses: psychological and relationship functioning within 1 month of treatment initiation

scientific article published on 17 September 2008

Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy

scientific article published on 01 February 2007

Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer

scientific article

Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy

scientific article

Objective evaluation of physical function in patients with advanced lung cancer: a preliminary report

scientific article published on 01 April 2006

Pattern and Predictors of Outpatient Palliative Care Referral Among Thoracic Medical Oncologists

scientific article published on 12 June 2018

Pemetrexed for treatment of advanced non-small cell lung cancer

scientific article published on February 2004

Pemetrexed in advanced NSCLC: a review of the clinical data.

scientific article

Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer

scientific article published on May 2010

Phase I Study of Weekly Alternating Therapy with Irinotecan/Cisplatin and Etoposide/Cisplatin for Patients with Small-Cell Lung Cancer ⬇️

scientific article published on July 1, 2003

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors

scientific article published on 9 March 2016

Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors

scientific article published on May 2004

Phase I trials of pemetrexed

scientific article

Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer

scientific article

Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)

scientific article published on 06 August 2019

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

scientific article published on 25 November 2019

Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report

scientific article

Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324

scientific article

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer

scientific article

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma

scientific article published in August 2005

Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy

scientific article published on April 2010

Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma

scientific article published on December 2011

Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer

scientific article published on 3 August 2009

Plasma biomarkers correlating with clinical outcome in a phase II study of sorafenib in advanced NSCLC

scientific article published on 01 January 2011

Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer

scientific article

Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials

scientific article published on 13 March 2013

Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy.

scientific article published in February 2014

Programmed Death Ligand 1 Heterogeneity and its Impact on Benefit from Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

scientific article published on 07 May 2020

Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer

scientific article published on 01 November 2006

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

scientific article

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group

scientific article

Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer

scientific article published on 3 August 2017

Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer

scientific article published on 01 November 2002

Second line chemotherapy for NSCLC: establishing a gold standard

scientific article published in December 2002

Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cance

scientific article published on 3 November 2017

Small cell lung cancer

scientific article published on 01 March 2008

Small cell lung cancer clinical practice guidelines in oncology

scientific article published on 01 July 2006

Targeted molecules in small cell lung cancer

scientific article published on February 2004

The BATTLE trial: personalizing therapy for lung cancer

scientific article

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer

scientific article published on August 2016

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

scientific article published on 16 February 2009

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy

scientific article

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres

scientific article published in April 2004

Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

scientific article published in January 2011

Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer

scientific article published in July 2002

Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma

scientific article published on May 2010

Paulina is supported by:

About Paulina

Help